293
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Antibodies to Lipids and Liposomes: Immunology and Safety

Pages 157-166 | Received 01 May 2006, Accepted 30 May 2006, Published online: 09 Dec 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zoltan Beck, Nicos Karasavvas, Gary R. Matyas & Carl R. Alving. (2008) Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes. Journal of Drug Targeting 16:7-8, pages 535-542.
Read now
Carl R. Alving, Zoltan Beck, Nicos Karasavva, Gary R. Matyas & Mangala Rao. (2006) HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies (Review). Molecular Membrane Biology 23:6, pages 453-465.
Read now

Articles from other publishers (17)

Gui Zhao, Yue Zhang, Cong-Fei Xu & Jun Wang. (2023) In vivo production of CAR-T cells using virus-mimetic fusogenic nanovesicles. Science Bulletin.
Crossref
Miusi Shi & Kevin J. McHugh. (2023) Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems. Advanced Drug Delivery Reviews 199, pages 114904.
Crossref
Barry Neun, Yechezkel Barenholz, Janos Szebeni & Marina Dobrovolskaia. (2018) Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro. Molecules 23:7, pages 1700.
Crossref
Shaoling Zhang, Kohsaku Kawakami, Lok Kumar Shrestha, Gladstone Christopher Jayakumar, Jonathan P. Hill & Katsuhiko Ariga. (2015) Totally Phospholipidic Mesoporous Particles. The Journal of Physical Chemistry C 119:13, pages 7255-7263.
Crossref
Tommy Tong, Ema T. Crooks, Keiko Osawa, James E. Robinson, Mary Barnes, Cristian Apetrei & James M. Binley. (2014) Multi-parameter exploration of HIV-1 virus-like particles as neutralizing antibody immunogens in guinea pigs, rabbits and macaques. Virology 456-457, pages 55-69.
Crossref
Barton F. Haynes, M. Anthony Moody, Hua-Xin Liao, Laurent Verkoczy & Georgia D. Tomaras. (2011) B cell responses to HIV-1 infection and vaccination: pathways to preventing infection. Trends in Molecular Medicine 17:2, pages 108-116.
Crossref
Wei-Yun Sheng & Leaf Huang. (2010) Cancer Immunotherapy and Nanomedicine. Pharmaceutical Research 28:2, pages 200-214.
Crossref
Markus R. Wenk. (2010) Lipidomics: New Tools and Applications. Cell 143:6, pages 888-895.
Crossref
M. Anthony Moody, Hua-Xin Liao, S. Munir Alam, Richard M. Scearce, M. Kelly Plonk, Daniel M. Kozink, Mark S. Drinker, Ruijun Zhang, Shi-Mao Xia, Laura L. Sutherland, Georgia D. Tomaras, Ian P. Giles, John C. Kappes, Christina Ochsenbauer-Jambor, Tara G. Edmonds, Melina Soares, Gustavo Barbero, Donald N. Forthal, Gary Landucci, Connie Chang, Steven W. King, Anita Kavlie, Thomas N. Denny, Kwan-Ki Hwang, Pojen P. Chen, Philip E. Thorpe, David C. Montefiori & Barton F. Haynes. (2010) Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines. Journal of Experimental Medicine 207:4, pages 763-776.
Crossref
Wim Jiskoot, Rianne M. F. van Schie, Myrra G. Carstens & Huub Schellekens. (2009) Immunological Risk of Injectable Drug Delivery Systems. Pharmaceutical Research 26:6, pages 1303-1314.
Crossref
Giulia Bonacucina, Marco Cespi, Monica Misici-Falzi & Giovanni F. Palmieri. (2009) Colloidal soft matter as drug delivery system. Journal of Pharmaceutical Sciences 98:1, pages 1-42.
Crossref
SJ Green. (2008) Clinical Development of TLR Agonists as Adjuvants: “Post-alum Adjuvant” Candidates May Reach Beyond Their Intended Purpose. Clinical Pharmacology & Therapeutics 83:6, pages 813-814.
Crossref
VEJC Schijns & WGJ Degen. (2008) Response to “‘Post-alum Adjuvants’ May Reach Beyond Their Intended Purpose: The Clinical Development of TLR Agonists”. Clinical Pharmacology & Therapeutics 83:6, pages 814-814.
Crossref
Carl R. Alving & Mangala Rao. (2008) Lipid A and liposomes containing lipid A as antigens and adjuvants. Vaccine 26:24, pages 3036-3045.
Crossref
Carl R Alving. (2008) 4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues. AIDS 22:5, pages 649-651.
Crossref
Brigitta Vcelar, Gabriela Stiegler, Hermann M Wolf, Wolfgang Muntean, Bettina Leschnik, Saurabh Mehandru, Martin Markowitz, Christine Armbruster, Renate Kunert, Martha M Eibl & Hermann Katinger. (2007) Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data. AIDS 21:16, pages 2161-2170.
Crossref
Bruce K. Brown, Nicos Karasavvas, Zoltan Beck, Gary R. Matyas, Deborah L. Birx, Victoria R. Polonis & Carl R. Alving. (2007) Monoclonal Antibodies to Phosphatidylinositol Phosphate Neutralize Human Immunodeficiency Virus Type 1: Role of Phosphate-Binding Subsites. Journal of Virology 81:4, pages 2087-2091.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.